Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine, Adriamycin, Actinomycin D, Ifosfamide in Ewing's Sarcoma
NCT00541411Phase 2Unknown
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jun 2003
- Primary completion
- Jun 2013
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
Phase 2 trial of vincristine, doxorubicin, actinomycin D and ifosfamide in Ewing sarcoma, sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Efficacy. Status: unknown.
02
Drugs
vincristinedoxorubicinactinomycin Difosfamide
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT00541411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541411.